Hims & Hers Health, Inc. (HIMS) Revenue Growth
Hims & Hers Health, Inc. (HIMS) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2020-12-31 | 80.18% |
| 2021-12-31 | 82.77% |
| 2022-12-31 | 93.81% |
| 2023-12-31 | 65.49% |
| 2024-12-31 | 69.33% |
| 2025-12-31 | 59.00% |
How HIMS compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AXSM | Axsome Therapeutics Inc. | 65.55% |
| LLY | Eli Lilly and Company | 44.70% |
| NTRA | Natera Inc. | 35.90% |
| KRYS | Krystal Biotech Inc. | 33.94% |
| PODD | Insulet Corporation | 30.73% |
These are five companies in the same sector as HIMS with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Hims & Hers Health, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("HIMS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HIMS | $28.44 | -3.85% | 7.28M |
| 3 | ||||
| 4 | ||||
| 5 |